Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omega Therapeutics Inc (NQ: OMGA )

2.220 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 668
Open 2.220
Bid (Size) 2.110 (3)
Ask (Size) 2.220 (1)
Prev. Close 2.220
Today's Range 2.220 - 2.220
52wk Range 1.300 - 7.790
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Ratings For Omega Therapeutics
Via Benzinga
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
From Omega Therapeutics
Via GlobeNewswire

Performance

YTD
-25.25%
-25.25%
1 Month
-10.12%
-10.12%
3 Month
-36.39%
-36.39%
6 Month
-1.33%
-1.33%
1 Year
-70.90%
-70.90%

More News

Read More
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
4 Analysts Have This To Say About Omega Therapeutics
Via Benzinga
How Is The Market Feeling About Omega Therapeutics?
Via Benzinga
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
From Omega Therapeutics
Via GlobeNewswire
OMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
From Omega Therapeutics
Via GlobeNewswire
OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The 3 Best Biotech Stocks to Buy in January 2024
Via InvestorPlace
Nvidia, Spotify Lead Five Stocks Near Buy Points
Via Investor's Business Daily
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review
Via Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
Via Investor's Business Daily
Why Novo Nordisk Stock Crushed the Market Today
Via The Motley Fool
Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.